Article info
PDFCancer genetics
Original article
Refining the role of pms2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants
- Correspondence to Dr Gabriel Capellá and Dr Marta Pineda, Hereditary Cancer Program, Catalan Institute of Oncology, ICO-IDIBELL, Gran Via 199-203, 08908 Hospitalet de Llobregat, Barcelona, Spain; gcapella@iconcologia.net and mpineda@iconcologia.net
Citation
Refining the role of pms2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants
Publication history
- Received January 3, 2013
- Revised April 25, 2013
- Accepted April 28, 2013
- First published May 24, 2013.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions